Analysis of influencing factors of metastasis and survival difference after endoscopic and surgical treatment in patients with gastric neuroendocrine tumors in stage T1-2 |
Received:October 16, 2022 Revised:November 15, 2022 Click here to download the full text |
Citation of this paper:BAI Bin,LI Heng,WANG Jun,JIANG Wei-ting,ZHU Xu-jun,XU Jian,CAI Hui.Analysis of influencing factors of metastasis and survival difference after endoscopic and surgical treatment in patients with gastric neuroendocrine tumors in stage T1-2[J].Chinese Journal of Clinical Medicine,2023,30(3):432-437 |
Hits: 848 |
Download times: 367 |
Author Name | Affiliation | E-mail | BAI Bin | Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China | | LI Heng | Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China | | WANG Jun | Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China | | JIANG Wei-ting | Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China | | ZHU Xu-jun | Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China | | XU Jian | Department of Gastrointestinal Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 201900, China | | CAI Hui | Department of General Surgery, the First Affiliated Hospital, Naval Medical University, Shanghai 200433, China | caihui@smmu.edu.cn |
|
Abstract:Objective To explore the metastasis rate of gastric neuroendocrine tumors (G-NETs) patients in stage T1-2 and its related risk factors, and to compare the long-term survival results of patients after endoscopic therapy (ET) and surgical treatment. Methods The data in SEER database were analyzed, and 1 258 patients with pathologically diagnosed G-NETs from January 1, 2004 to December 31, 2015 were included. Logistic regression was used to analyze the influencing factors of metastasis of patients with G-NETs. In patients with T1-2N0M0 stage G-NETs, the general clinical characteristics of patients receiving ET or surgery were compared after propensity matching analysis. The difference of 5-year overall survival (OS) and the risk factors affecting OS between the surgery and ET groups were analyzed by Kaplan-Meier survival curve and Cox proportional hazard regression model. Results A total of 851 patients with T1 and T2 G-NETs were followed up for 5 years. Lymph node or distant metastasis occurred in 183 patients (21.5%). The metastasis rates of T1 and T2 G-NETs patients were 14.6% and 33.3%, respectively (P<0.05). Multivariate logistic regression analysis showed that tumor grade G3/4, invasion of lamina propria and tumor diameter >20 mm were closely related to metastasis of T1-2 stage G-NETs. The 5-year survival rate of patients in non-metastasis group (n=668) was 85.1%, and that of patients in metastasis group (n=183) was 34.7% (P<0.05). Subgroup analysis showed that during the 5-year follow-up, the average survival time of patients with metastasis after surgery and ET treatment was 42.0 months and 31.3 months (χ2=14.510, P<0.05), and the average survival time of patients without metastasis after surgery and ET treatment was 53.2 months and 52.3 months (χ2=0.279, P=0.598). After propensity matching analysis, the 5-year survival rate of patients with T1-2N0M0 G-NETs was similar after ET and surgery (88.8% vs 89.4%, χ2=0.22, P=0.882). Multivariate Cox proportional hazard regression model showed that age, histological grade and depth of invasion were related to OS of patients with T1-2N0M0 G-NETs. Conclusions The tumor grade G3/4, invasion of lamina propria and tumor diameter > 20 mm might be closely related to the metastasis of G-NET in T1-2 stage, the prognosis of these patients with metastasis is poor. 5-year survival rate in patients with T1~2N0M0 G-NETs are similar after ET and surgery. |
keywords:gastric neuroendocrine tumors endoscopic therapy surgery SEER database |
HTML View Full Text View/Add Comment Download reader |
|
|
|